Portfolio company
Greenstone Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides stem cell-derived models and artificial intelligence platforms to pharmaceutical companies and academic researchers for drug discovery and toxicity testing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
PIXL BIO
This company develops human iPSC-derived cell models and AI-powered phenomics software for pharmaceutical firms to conduct predictive drug discovery and safety assessments.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
StemoniX
This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.
Techbio 2.0
This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Anto Biosciences
This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.
